MabPlex is a contract development and manufacturing organization (CDMO) providing comprehensive biomanufacturing services for biologics, including antibody-drug conjugates (ADCs). The company offers innovative CRO services and commercial fill/finish capabilities to help clients achieve FDA IND approval and commercialize their programs.
AI named MabPlex CMO from January 2026 to August 2026.
Brand page for mabplexinc-com